New diabetes clinical trial: Investigating Neurocognitive Disorders Epidemiology

Published on: April 18, 2024 at 11:00PM
Conditions: Dementia; Cognitive Decline; Alzheimer Disease
Interventions: Diagnostic Test: Plasma tau phosphorylated at Thr217; Other: Neurocognitive examination
Sponsors: King Chulalongkorn Memorial Hospital; Health Systems Research Institute,Thailand
Recruiting
https://ift.tt/5o6DYEh